An antinociceptive role of galanin in the arcuate nucleus of hypothalamus in intact rats and rats with inflammation

Pain

Volumn 106, Issue 1-2, 2003, Pages 143-150

  Sun, Yan Gang ^a   Gu, Xing Long ^a   Lundeberg, Thomas ^b   Yu, Long Chuan ^a  

^a PEKING UNIVERSITY   (China)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Antinociception; Arcuate nucleus; Galanin; Galanin receptors; Hyperalgesia; Inflammation

Indexed keywords

GALANIN; GALANIN RECEPTOR; GALANIN RECEPTOR ANTAGONIST; GALANTIDE; RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARCUATE NUCLEUS; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; HOT PLATE TEST; HYPOTHALAMUS; INFLAMMATION; MALE; MECHANICAL STIMULATION; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT; THERMAL STIMULATION; WITHDRAWAL REFLEX;

EID: 0142165204     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(03)00316-6     Document Type: Article

References (48)

1. Bach F.W. Beta-endorphin in the brain. A role in nociception. Acta Anaesthesiol Scand. 41:1997;133-140.
2. Barton C., Lin L., York D.A., Bray G.A. Differential effects of enterostatin, galanin and opioids on high-fat diet consumption. Brain Res. 702:1995;55-60.
3. Bedecs K., Berthold M., Bartfai T. Galanin - 10 years with a neuroendocrine peptide. Int J Biochem Cell Biol. 27:1995;337-349.
4. Behbehani M.M. Functional characteristics of the midbrain periaqueductal gray. Prog Neurobiol. 46:1995;575-605.
5. Blakeman K.H., Hao J.X., Xu X.J., Jacoby A.S., Shine J., Crawley J.N., Iismaa T., Wiesenfeld-Hallin Z. Hyperalgesia and increased neuropathic pain-like response in mice lacking galanin receptor 1 receptors. Neuroscience. 117:2003;221-227.
6. Bloom F., Battenberg E., Rossier J., Ling N., Guillemin R. Neurons containing beta-endorphin in rat brain exist separately from those containing enkephalin: immunocytochemical studies. Proc Natl Acad Sci USA. 75:1978;1591-1595.
7. Bouret S., Croix D., Mariot M., Loyens A., Prevot V., Jegou S., Vaudry H., Beauvillain J.C., Mitchell V. Galanin modulates the activity of proopiomelanocortin neurons in the isolated mediobasal hypothalamus of the male rat. Neuroscience. 112:2002;475-485.
8. Bouret S., Prevot V., Croix D., Howard A., Habert-Ortoli E., Jegou S., Vaudry H., Beauvillain J.C., Mitchell V. Expression of GalR1 and GalR2 galanin receptor messenger ribonucleic acid in proopiomelanocortin neurons of the rat arcuate nucleus: effect of testosterone. Endocrinology. 141:2000;1780-1794.
9. Branchek T.A., Smith K.E., Gerald C., Walker M.W. Galanin receptor subtypes. Trends Pharmacol Sci. 21:2000;109-117.
10. Colvin L.A., Mark M.A., Duggan A.W. The effect of a peripheral mononeuropathy on immunoreactive (ir)-galanin release in the spinal cord of the rat. Brain Res. 766:1997;259-261.
11. Cowley M.A., Smart J.L., Rubinstein M., Cerdan M.G., Diano S., Horvath T.L., Cone R.D., Low M.J. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature. 411:2001;480-484.
12. Dube M.G., Horvath T.L., Leranth C., Kalra P.S., Kalra S.P. Naloxone reduces the feeding evoked by intracerebroventricular galanin injection. Physiol Behav. 56:1994;811-813.
13. Finley J.C., Lindstrom P., Petrusz P. Immunocytochemical localization of beta-endorphin-containing neurons in the rat brain. Neuroendocrinology. 33:1981;28-42.
14. Flatters S.J., Fox A.J., Dickenson A.H. Nerve injury induces plasticity that results in spinal inhibitory effects of galanin. Pain. 98:2002;249-258.
15. Floren A., Land T., Langel U. Galanin receptor subtypes and ligand binding. Neuropeptides. 34:2000;331-337.
16. Gundlach A.L. Galanin/GALP and galanin receptors: role in central control of feeding, body weight/obesity and reproduction? Eur J Pharmacol. 440:2002;255-268.
17. Heppelmann B., Just S., Pawlak M. Galanin influences the mechanosensitivity of sensory endings in the rat knee joint. Eur J Neurosci. 12:2000;1567-1572.
18. Horvath T.L., Kalra S.P., Naftolin F., Leranth C. Morphological evidence for a galanin-opiate interaction in the rat mediobasal hypothalamus. J Neuroendocrinol. 7:1995;579-588.
19. Iismaa T.P., Shine J. Galanin and galanin receptors. Results Prob Cell Differ. 26:1999;257-291.
20. Ji R.R., Zhang Q., Bedecs K., Arvidsson J., Zhang X., Xu X.J., Wiesenfeld-Hallin Z., Bartfai T., Hokfelt T. Galanin antisense oligonucleotides reduce galanin levels in dorsal root ganglia and induce autotomy in rats after axotomy. Proc Natl Acad Sci USA. 91:1994;12540-12543.
21. Kerr B.J., Gupta Y., Pope R., Thompson S.W., Wynick D., McMahon S.B. Endogenous galanin potentiates spinal nociceptive processing following inflammation. Pain. 93:2001;267-277.
22. Kinney G.A., Emmerson P.J., Miller R.J. Galanin receptor-mediated inhibition of glutamate release in the arcuate nucleus of the hypothalamus. J Neurosci. 18:1998;3489-3500.
23. Kuraishi Y., Kawamura M., Yamaguchi T., Houtani T., Kawabata S., Futaki S., Fujii N., Satoh M. Intrathecal injections of galanin and its antiserum affect nociceptive response of rat to mechanical, but not thermal, stimuli. Pain. 44:1991;321-324.
24. Liu H.X., Brumovsky P., Schmidt R., Brown W., Payza K., Hodzic L., Pou C., Godbout C., Hokfelt T. Receptor subtype-specific pronociceptive and analgesic actions of galanin in the spinal cord: selective actions via GalR1 and GalR2 receptors. Proc Natl Acad Sci USA. 98:2001;9960-9964.
25. Liu H.X., Hokfelt T. Effect of intrathecal galanin and its putative antagonist M35 on pain behavior in a neuropathic pain model. Brain Res. 886:2000;67-72.
26. Liu H.X., Hokfelt T. The participation of galanin in pain processing at the spinal level. Trends Pharmacol Sci. 23:2002;468-474.
27. Ma W., Bisby M.A. Differential expression of galanin immunoreactivities in the primary sensory neurons following partial and complete sciatic nerve injuries. Neuroscience. 79:1997;1183-1195.
28. Melander T., Hokfelt T., Rokaeus A. Distribution of galaninlike immunoreactivity in the rat central nervous system. J Comp Neurol. 248:1986;475-517.
29. Merchenthaler I., Lopez F.J., Negro-Vilar A. Anatomy and physiology of central galanin-containing pathways. Prog Neurobiol. 40:1993;711-769.
30. Paxinos G., Watson C. The rat brain in stereotaxic coordinates. 1998;Academic Press, Sydney.
31. Pilcher W.H., Joseph S.A., McDonald J.V. Immunocytochemical localization of pro-opiomelanocortin neurons in human brain areas subserving stimulation analgesia. J Neurosurg. 68:1988;621-629.
32. Pooga M., Soomets U., Hallbrink M., Valkna A., Saar K., Rezaei K., Kahl U., Hao J.X., Xu X.J., Wiesenfeld-Hallin Z., Hokfelt T., Bartfai T., Langel U. Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo. Nat Biotechnol. 16:1998;857-861.
33. Rada P., Mark G.P., Hoebel B.G. Galanin in the hypothalamus raises dopamine and lowers acetylcholine release in the nucleus accumbens: a possible mechanism for hypothalamic initiation of feeding behavior. Brain Res. 798:1998;1-6.
34. Rajendren G. Increased galanin synapses onto activated gonadotropin-releasing hormone neuronal cell bodies in normal female mice and in functional preoptic area grafts in hypogonadal mice. J Neuroendocrinol. 14:2002;435-441.
35. Sandkuhler J. The organization and function of endogenous antinociceptive systems. Prog Neurobiol. 50:1996;49-81.
36. Sim L.J., Joseph S.A. Arcuate nucleus projections to brainstem regions which modulate nociception. J Chem Neuroanat. 4:1991;97-109.
37. Skofitsch G., Jacobowitz D.M. Quantitative distribution of galanin-like immunoreactivity in the rat central nervous system. Peptides. 7:1986;609-613.
38. Tatemoto K., Rokaeus A., Jornvall H., McDonald T.J., Mutt V. Galanin - a novel biologically active peptide from porcine intestine. FEBS Lett. 164:1983;124-128.
39. Vaughan C.W., Ingram S.L., Connor M.A., Christie M.J. How opioids inhibit GABA-mediated neurotransmission. Nature. 390:1997;611-614.
40. Wang D., Lundeberg T., Yu L.C. Antinociceptive role of galanin in periaqueductal grey of rats with experimentally induced mononeuropathy. Neuroscience. 96:2000;767-771.
41. Wang D., Ye H.H., Yu L.C., Lundeberg T. Intra-periaqueductal grey injection of galanin increases the nociceptive response latency in rats, an effect reversed by naloxone. Brain Res. 834:1999;152-154.
42. Wiesenfeld-Hallin Z., Xu X.J. Neuropeptides in neuropathic and inflammatory pain with special emphasis on cholecystokinin and galanin. Eur J Pharmacol. 429:2001;49-59.
43. Xu S.L., Zhang Y.P., Lundeberg T., Yu L.C. Effects of galanin on wide-dynamic range neuron activity in the spinal dorsal horn of rats with sciatic nerve ligation. Regul Pept. 95:2000;19-23.
44. Yu L.C., Hansson P., Lundeberg T. The calcitonin gene-related peptide antagonist CGRP8-37 increases the latency to withdrawal responses bilaterally in rats with unilateral experimental mononeuropathy, an effect reversed by naloxone. Neuroscience. 71:1996;523-531.
45. Yu L.C., Lundeberg S., An H., Wang F.X., Lundeberg T. Effects of intrathecal galanin on nociceptive responses in rats with mononeuropathy. Life Sci. 64:1999;1145-1153.
46. Yu L.C., Xu S.L., Xiong W., Lundeberg T. The effect of galanin on wide-dynamic range neuron activity in the spinal dorsal horn of rats. Regul Pept. 101:2001;179-182.
47. Zangen A., Herzberg U., Vogel Z., Yadid G. Nociceptive stimulus induces release of endogenous beta-endorphin in the rat brain. Neuroscience. 85:1998;659-662.
48. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 16:1983;109-110.